1175543-03-9

1175543-03-9 - Names and Identifiers

Name	2α,9α,11-Trihydroxy-6-oxodrim-7-ene
Synonyms	2α,9α,11-Trihydroxy-6-oxodrim-7-ene 2alpha,9alpha,11-Trihydroxy-6-oxodrim-7-ene 1(4H)-Naphthalenone, 4a,5,6,7,8,8a-hexahydro-4,6-dihydroxy-4-(hydroxymethyl)-3,4a,8,8-tetramethyl-, (4R,4aS,6S,8aS)-
CAS	1175543-03-9

1175543-03-9 - Physico-chemical Properties

Molecular Formula	C15H24O4
Molar Mass	268.35
Density	1.165±0.06 g/cm3(Predicted)
Boling Point	436.8±45.0 °C(Predicted)
Appearance	Powder
pKa	12.52±0.70(Predicted)
Storage Condition	2-8℃

1175543-03-9 - Introduction

The chemical name is 2α,9α, and the radical compound is a natural product, also known as alirone.

The compound exists in the plant Del. (Gentiana) and has special physiological activity. Its molecular formula is C15H20O4 and its relative molecular mass is 264.32g/mol.

The following are the properties of 2α,9α, Ni:

Appearance: A white to light yellow crystalline powder.
Melting point: About 156-159 ℃.
Solubility: Soluble in ethanol, dimethylformamide and other polar organic solvents.
Stability: It is relatively stable under light, but it will degrade under acidic conditions.

2α,9α, the use of the pill mainly includes the following aspects:

1. Drug research: The compound has anti-inflammatory, antioxidant and antimicrobial activities, and is widely used in the field of drug research and development.

The common method for preparing 2α,9α, and 2α is to extract and isolate from DspA. Extraction methods include extraction using a solvent (e. G., ethanol) followed by purification using techniques such as column chromatography, liquid-liquid partitioning, and the like.

There is no specific safety information report on 2α,9α, 2α. However, the handling and use of chemical substances always requires safety measures, such as wearing gloves, goggles, etc. It is recommended that the relevant operations be carried out under laboratory conditions with suitable equipment and environment, and in accordance with relevant regulations and guidelines.

Last Update：2024-04-09 19:05:57